Original Article

You have full text access to this OnlineOpen article

Underuse of colorectal cancer screening in a cohort of medicare beneficiaries†

  1. Gregory S. Cooper MD1,2,‡,*,
  2. Tzuyung Doug Kou MPH, MA2

Article first published online: 10 DEC 2007

DOI: 10.1002/cncr.23176

Issue

Cancer

Cancer

Volume 112, Issue 2, pages 293–299, 15 January 2008

Additional Information

How to Cite

Cooper, G. S. and Doug Kou, T. (2008), Underuse of colorectal cancer screening in a cohort of medicare beneficiaries. Cancer, 112: 293–299. doi: 10.1002/cncr.23176

Author Information

  1. 1

    Division of Gastroenterology, University Hospitals Case Medical Center, Cleveland, Ohio

  2. 2

    Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio

  1. ‡

    Fax: (216) 983-0347

*Division of Gastroenterology, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106-5066

  1. †

    Presented in part at Digestive Disease Week, Washington DC, 20–23, May 2007 and published in abstract form in Gastroenterology. 2007;132:A-89 and 132:A-622.This study used the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, National Cancer Institute; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database.

Publication History

  1. Issue published online: 4 JAN 2008
  2. Article first published online: 10 DEC 2007
  3. Manuscript Accepted: 19 OCT 2007
  4. Manuscript Revised: 16 AUG 2007
  5. Manuscript Received: 27 JUN 2007

Funded by

  • Research Project Grant. Grant Number: RSGT-01-072-03-CPHPC
  • American Cancer Society

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (88K)

REFERENCES

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun M. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43–66.
    Direct Link:
  • 2
    Smith RA,Cokkinides V,Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices and prospects. CA Cancer J Clin. 2007; 57: 90–104.
    Direct Link:
  • 3
    Winawer S,Fletcher R,Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale — update based on new evidence. Gastroenterology. 2003; 124: 544–560.
  • 4
    United States Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 129–131.
  • 5
    Rex DK,Johnson DA,Lieberman DA,Burt RW,Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000; 95: 868–877.
  • 6
    Health Care Financing Administration. Medicare coverage of colorectal cancer screening. Transmittal No. AB-97–24. Washington, DC: Health Care Financing Administration; 1997.
  • 7
    Health Care Financing Administration. Billing for colorectal screening. Transmittal No. 769. Washington, DC: Health Care Financing Administration; 2001.
  • 8
    U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. Washington, DC: U.S. Department of Health and Human Services; 2000.
  • 9
    Centers for Disease Control and Prevention. Increased use of colorectal cancer tests—United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep. 2006; 55: 308–311.
  • 10
    Phillips KA,Liang S,Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007; 45: 160–167.
  • 11
    Winawer SJ,Zauber AG,Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130: 1872–1885.
  • 12
    Potosky AL,Riley GF,Lubitz JD,Mentnech RM,Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993; 31: 732–748.
  • 13
    Warren JL,Klabunde CN,Schrag D,Bach PB,Riley GF. Overview of the SEER-Medicare data. Med Care. 2002; 40: IV-3–IV-18.
  • 14
    Charlson ME,Pompei P,Ales KL,MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373–383.
  • 15
    Deyo RA,Cherkin DC,Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613–619.
  • 16
    Chu KC,Tarone RE,Chow W-H,Hankey BF,Ries LAG. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994; 86: 997–1006.
  • 17
    Ko CW,Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology. 2005; 129: 1163–1170.
  • 18
    Lin OS,Kozarek RA,Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006; 295: 2357–2365.
  • 19
    Ko CW,Kreuter W,Baldwin L-M. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002; 162: 2581–2586.
  • 20
    Richards RJ,Reker DM. Racial differences in use of colonoscopy, sigmoidoscopy and barium enema in Medicare beneficiaries. Dig Dis Sci. 2002; 47: 2715–2719.
  • 21
    Ananthakrishnan AN,Schellhase KG,Sparapani RA,Laud PW,Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007; 167: 258–264.
  • 22
    Cooper GS,Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004; 100: 418–424.
    Direct Link:
  • 23
    Rabeneck L,Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004; 99: 1141–1144.
    Direct Link:
View Full Article (HTML) Get PDF (88K)